Products & Services · Revenues:

All Other Hospital and Biosimilars — Revenues:

Pfizer All Other Hospital and Biosimilars — Revenues: increased by 5.8% to $953.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementSegment
First reportedQ1 2025
Last reportedQ1 2026May 5, 2026
Rolls up toTotal Revenue
Metric ID: pfe_segment_all_other_hospital_and_biosimilars_revenues

Historical Data

2 periods
 Q1 '25Q1 '26
Value$901.00M$953.00M
QoQ Change—+5.8%
YoY Change—+5.8%
Range$901.00M – $953.00M
Avg YoY Growth+5.8%
Median YoY Growth+5.8%

Frequently Asked Questions

What is Pfizer's all other hospital and biosimilars — revenues:?
Pfizer (PFE) reported all other hospital and biosimilars — revenues: of $953.00M in Q1 2026.